Michael Scolaro

Michael Scolaro

Oct 07, 2017

Group 6 Copy 215
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can treatment with natural medicine be used to prevent Parkinson's symptoms?

Aggregation of the synuclein-alpha, SNCA, protein can indicate Parkinson's Disease, PD, symptoms two years prior...

From Minerals to Medicines: A New Technology for Heavy Metal Pollution Remediation

This is the first part of a multi-phase experiment in which I will prove that substances isolated from plant...

Detection of Zika virus rapidly without the need for a laboratory in Brazil

Zika (PORTUGUESE) is a rapidly emerging pandemic, a global health emergency. ZIKV has been associated with central...

Backer Badge Funded